Paper Details

  1. Home
  2. Paper Details

The presence of a pituitary tumor in patients with prostate cancer is not a contraindication for leuprolide therapy.

Author: BabboAngela, BajramovicSanija, ChandlerJames P, GarnettJohn, KalapurakalGeorge T, KalapurakalJohn A, LiuBenjamin

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This report examined whether the presence of a pituitary tumor is a contraindication for leuprolide therapy in patients with prostate cancer, given reports of pituitary apoplexy following leuprolide therapy.
Paper Details　
Original Abstract of the Article :
Gonadotropin analogs like leuprolide play an important role in the management of prostate cancer. Pituitary apoplexy has been reported after leuprolide therapy. This report examines whether the presence of a pituitary tumor is a contraindication for leuprolide therapy in patients with prostate cance...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/s11255-014-0708-z

データ提供：米国国立医学図書館（NLM）

Leuprolide Therapy and Pituitary Tumors: A Case for Informed Decision-Making

The treatment of [prostate cancer] often involves [gonadotropin analogs] like [leuprolide], which can have various effects on the endocrine system. This study investigates the potential risks associated with using leuprolide therapy in patients with [pituitary tumors]. The researchers examine whether the presence of a pituitary tumor is a contraindication for leuprolide therapy in patients with prostate cancer.

Leuprolide Therapy and Pituitary Tumors: Careful Consideration Needed

The study suggests that the presence of a pituitary tumor may not necessarily preclude the use of leuprolide therapy in patients with prostate cancer. However, it emphasizes the importance of careful consideration and informed decision-making, weighing the potential benefits and risks of this treatment approach.

Personalized Treatment Approaches for Prostate Cancer

This study, like a careful traveler navigating the shifting sands of prostate cancer treatment, underscores the need for individualized care. It highlights the importance of a comprehensive evaluation of patient factors, including the presence of pituitary tumors, to determine the most appropriate treatment strategy.

Dr.Camel's Conclusion

This study is like a camel caravan navigating a desert landscape, where each sand dune represents a different factor to consider when treating prostate cancer. The findings emphasize the importance of careful consideration and individualized care to ensure the best possible outcome for each patient.

Date :
  1. Date Completed 2015-05-14
  2. Date Revised 2021-10-21
Further Info :

Pubmed ID

24705727

DOI: Digital Object Identifier

10.1007/s11255-014-0708-z

Related Literature

Article Analysis
・Effects of leuprolide injection
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.